BIIB Income Statement

Click line-items for a historical chart and %
Revenues:
Product 1.07B
Unconsolidated joint business 280.95M
Other 62.32M
Total revenues 1.42B
Cost and expenses:
Cost of sales, excluding amortization of acquired intangible assets 133.83M
Research and development 345.18M
Selling, general and administrative 375.98M
Collaboration profit sharing 77.95M
Amortization of acquired intangible assets 50.95M
Acquired in-process research and development
Restructuring charge 0
Fair value adjustment of contingent consideration 3.63M
Total cost and expenses 987.51M
Income from operations 445.51M
Other income (expense), net -14.29M
Income before income tax expense 431.22M
Income tax expense 136.34M
Net income 292.13M
Net income attributable to noncontrolling interests, net of tax 0
Net income attributable to Biogen Idec Inc. 292.13M
Net income per share:
Basic earnings per share attributable to Biogen Idec Inc. 1.24
Diluted earnings per share attributable to Biogen Idec Inc. 1.23
Weighted-average shares used in calculating:
Basic earnings per share attributable to Biogen Idec Inc. -477.28M
Diluted earnings per share attributable to Biogen Idec Inc. -480.84M

Entities mentioned with BIIB

View All Entities